$Guess?(GES)$ Predicting the future price of Guess? Inc. (GES) in 2025 is speculative: 1. Consumer Spending Trends 2. Brand and Product Innovation 3. Macroeconomic Factors 4. Operational Efficiency Speculative Prediction: • Bullish Case: If the company sustains growth initiatives and macro conditions improve, GES could trade in the $20–$25 range. • Neutral Case: With steady but unspectacular performance, the stock might hover around $15–$20. • Bearish Case: Significant challenges could see the stock dip below $12.
Here are several reasons why Elevance Health (ELV) stock could be considered a buy in 2025: 1. Medicare Advantage Growth 2.Strong Financial Fundamentals 3. Diverse Business Portfolio 4. Valuation and Recovery Potential 5. Strategic Initiatives 6. Favorable Industry Trends Caution: While Elevance has growth potential, it’s essential to monitor regulatory changes, competitive pressures, and medical cost trends. Balancing these risks with its strengths can help in making an informed decision. Could go upwards movement in between 30%-60%
With that in mind, I believe the upcoming earnings reports from Citigroup, Wells Fargo, Goldman Sachs, and JPMorgan could reflect resilience and adaptability, especially in a challenging economic climate. Higher interest rates might drive stronger net interest margins, and careful cost management could support steady performance. While challenges like credit quality and market volatility remain, I’m optimistic about their ability to navigate and deliver solid results, setting a confident tone for the broader earnings season.
Let’s go, team! 🚀 The 2025 Tiger Brokers Trading Challenge is our chance to shine. Stay focused, trade smart, and support each other every step of the way. Together, we can achieve great results. Believe in yourself and let’s make this challenge ours! 💪
Sound great news for Micron. Especially Micron dont have any China companies. Previous 4-5 year ago, 40% of Micron business were depended on China companies.